Results The nanogel exhibited 99.6 nm particle size, 33.0 mV zeta potential, 91.6% entrapment efficiency, and sustained GLU release (87% at 24h)
The next, phase 1b clinical trial in adults with T2DM compared once weekly retatrutide (0.5, 1.5, 3, 3 mg starting dose increased to 6, 3 mg starting dose increased to 12 mg) versus placebo versus dulaglutide 1.5 mg over 12 weeks [63]
Flaws but not dealbreakers The emollient formula gums up the dropper and gloms on to the bottle, making the experience untidy
Astra Labs products are not medicines and are supplied strictly for laboratory research use only
As pipeline agents expand the therapeutic landscape and indications extend into neurology, hepatology, and addiction medicine, physicians who invest in building GLP-1 competency now will be best positioned to lead metabolic care in the coming decade
In tumors, the balance between mitochondrial quality control and metal-induced cell death must be disrupted to promote tumor cell death